Navigation Links
BioElectronics Corporation Announces New Website for Italian Market
Date:4/29/2008

ACTIPATCH.IT WEBSITE LAUNCHES

FREDERICK, Md., April 29 /PRNewswire-FirstCall/ -- BioElectronics Corporation, (Pink Sheets: BIEL), announced a new website, http://www.actipatch.it is now selling the ActiPatch products to the Italian market. TSS Medical, (Tecnica Scientifica Service), designed the site to reach both pharmacies and consumers in Italy. TSS Medical is a medical provider and distributor to Italy's retail pharmacies and is headquartered in Torino, Italy. Over 10,000 ActiPatch units were acquired by TSS Medical to initiate the retail product launch.

ActiPatch is a wafer thin patch with a microcurrent that has been shown to reduce pain and swelling and accelerate healing with no known side effects. The science behind ActiPatch is well-proven and has been successfully used as an office based therapy for many years. BioElectronics Corporation, through it's ActiPatch product, makes this technology available for use in any setting in an easy to wear patch that is placed directly over the soft tissue injury or surgical incision. ActiPatch is drug-free, simple to use and in most cases relieves pain and swelling very quickly. ActiPatch may also be a cost-effective alternative to OTC and prescription medications. Physicians are so impressed with the power of the patch that they are recommending ActiPatch for surgical recovery, sports injuries and other of aches, pains and soft tissue injuries.

Alessio Petricca, Head of Marketing and Operations of TSS Medical explains, "TSS Medical has had an exceptional response to the ActiPatch products, both at the ESRA Congress in Salerno and at the Congress of Chronic Pain in Genoa. The market potential for this innovative, drug-free therapy is enormous." The new website, http://www.actipatch.it provides an informative, easy to use sales channel for the ActiPatch products. Petricca promises that enhancements to the beautifully designed site are coming in the near future.

"We are watching the success of TSS Medical and their new website with great excitement," says Andrew Whelan, CEO of Bioelectronics Corporation. "This may be the beginning of our products becoming a worldwide choice for a drug free, cost-effective treatment for pain and swelling," adds Whelan.

About TSS Medical:

TSS Medical was established in 1998 and employs 40 sales agents. TSS is headquartered in Torino, Italy and maintains ISO 9000 TUV certification. The company distributes medications and medical devices for postoperative recovery and chronic pain for such leading companies as On Q, Vertis PNT, Anodyne Therapy and others.

For more information visit http://www.tssmedical.com.

About BioElectronics:

BioElectronics Corporation is the maker of ActiPatch(TM). ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

For more information visit http://www.bioelectronicscorp.com

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.

Contact: Patricia Baker

413-623-0950

pbaker@bigpictureagency.com


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond
2. BioElectronics Corporations New Commercial Airing Nationally Advertising Initiative Will Reach 15,000,000 Homes Nationwide
3. BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11
4. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
5. BioElectronics Corporation Receives 2007 Economic Development Innovator of the Year Award
6. DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
7. Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement
8. HTG-Ventrex, Signalifes Contract Manufacturer, Acquired by Parker Hannifin Corporation
9. Torchmark Corporation Declares Dividend
10. Steris Corporation Announces the Appointment of Two New Directors
11. Digirad Corporation Reports Financial Results for First-Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... New York, NY (PRWEB) , ... March 23, 2017 , ... 82% of adults are ... every 3 kids do not brush their teeth the minimum two times a day that ... teeth; with students missing 51 million hours of school and adults missing 164 million hours ...
(Date:3/23/2017)... Los Angeles, CA (PRWEB) , ... March 23, ... ... Series A funding investment in Los Angeles based healthcare technology company California Healthcom ... group’s portfolio into the US, and healthcare arena. With headquarters in California, CHG ...
(Date:3/23/2017)... ... 2017 , ... After raising more than $1.135 million ($1,479,231 AUD) from nearly ... in crowdfunding history, has established a U.S. Headquarters in New York City, FaceCradle ... , “We’re excited to be operating on U.S. shores, where most of our initial ...
(Date:3/23/2017)... ... 23, 2017 , ... According to the National Sleep Foundation , poor ... the only cause of the sunken-eye look, which can include dark circles or bags ... poor health are likely due to genetics, dehydration, allergies, and losing fat beneath the ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance ... Anniversary of ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , ... only to the association, but also to the Health Care Quality and Patient Safety ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... VANCOUVER, British Columbia , March 23, 2017 /PRNewswire/ ... "Company" or "Sophiris"), a clinical late-stage biopharmaceutical company developing ... announced that data from its successful Phase 2a study ... treatment for localized prostate cancer, will be presented as ... nd Annual European Association of Urology in ...
(Date:3/23/2017)... 2017  Ethicon* today announced the completion of ... held medical device company that manufactures and markets ... treatment of Gastroesophageal Reflux Disease (GERD). This acquisition ... portfolio of minimally invasive options for patients suffering ... of the transaction have not been disclosed. ...
(Date:3/23/2017)... LITTLE SILVER, N.J. , March 23, 2017 ... device company, today announced that it has kicked ... in-growth into their 3D printed bone segments. ... of Engineering, "Our unique variable honeycomb lattice structures ... bone in-growth as compared to current allograft wedges ...
Breaking Medicine Technology: